raymond james financial inc. - RJF
RJF
Close Chg Chg %
162.19 1.58 0.97%
Closed Market
163.77
+1.58 (0.97%)
Volume: 742.56K
Last Updated:
Nov 21, 2024, 3:59 PM EDT
Company Overview: raymond james financial inc. - RJF
RJF Key Data
Open $162.63 | Day Range 162.11 - 164.71 |
52 Week Range 102.42 - 164.71 | Market Cap $32.97B |
Shares Outstanding 203.30M | Public Float 182.91M |
Beta 1.00 | Rev. Per Employee N/A |
P/E Ratio 16.72 | EPS $9.95 |
Yield 110.99% | Dividend $0.45 |
EX-DIVIDEND DATE Oct 1, 2024 | SHORT INTEREST N/A |
AVERAGE VOLUME 1.23M |
RJF Performance
1 Week | 0.93% | ||
1 Month | 11.92% | ||
3 Months | 38.86% | ||
1 Year | 53.77% | ||
5 Years | 175.16% |
RJF Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
17
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
Average Recommendation | OVERWEIGHT | Average Target Price | 146.462 | |
Number of Ratings | 17 | Current Quarters Estimate | 2.616 | |
FY Report Date | 12 / 2024 | Current Year's Estimate | 10.376 | |
Last Quarter’s Earnings | 2.95 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 10.05 | Next Fiscal Year Estimate | 11.083 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 13 | 12 | 15 | 13 |
Mean Estimate | 2.62 | 2.46 | 10.38 | 11.08 |
High Estimates | 2.88 | 2.75 | 11.46 | 11.98 |
Low Estimate | 2.29 | 2.21 | 9.48 | 10.05 |
Coefficient of Variance | 6.45 | 5.43 | 6.02 | 5.48 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 6 | 6 | 4 |
OVERWEIGHT | 0 | 0 | 0 |
HOLD | 10 | 10 | 12 |
UNDERWEIGHT | 1 | 0 | 0 |
SELL | 0 | 0 | 0 |
MEAN | Overweight | Overweight | Hold |
SEC Filings for Raymond James Financial Inc. - RJF
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Raymond James Financial Inc. - RJF
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
May 24, 2024 | Estate Of Robert M Dutkowsky Director | 1,481 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
May 24, 2024 | Estate Of Robert M Dutkowsky Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
May 24, 2024 | Estate Of Robert M Dutkowsky Director | 662 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 22, 2024 | James E. Bunn Pres-GlobEq&Inv Banking-RJA | 19,775 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
May 1, 2024 | Bella Loykhter Allaire Executive Vice President-RJA | 92,949 | Bona fide gift | 0.00 |
Apr 30, 2024 | Steven M. Raney President & CEO RJBank | 51,009 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $121.01 per share | 6,172,599.09 |
Apr 12, 2024 | Art A. Garcia Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Apr 12, 2024 | Art A. Garcia Director | 2,725 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 7, 2024 | Shannon B Reid President, ICD for RJFS | 7,316 | Bona fide gift | 0.00 |
Feb 27, 2024 | Anne Gates Director | 3,354 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 27, 2024 | Gordon L. Johnson Director | 40,642 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 27, 2024 | Gordon L. Johnson Director | 3,992 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 27, 2024 | Gordon L. Johnson Director | 4,334 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 27, 2024 | Gordon L. Johnson Director | 40,323 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 27, 2024 | Gordon L. Johnson Director | 40,004 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 27, 2024 | Benjamin C. Esty Director | 1,711 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 27, 2024 | Raymond W. McDaniel Director | 1,711 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 27, 2024 | Benjamin C. Esty Director | 3,354 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 27, 2024 | Gordon L. Johnson Director | 4,038 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 27, 2024 | Gordon L. Johnson Director | 4,357 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |